{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:05:45Z","timestamp":1793225145254,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22mk0101214"],"award-info":[{"award-number":["JP22mk0101214"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-22425-0","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T18:59:53Z","timestamp":1762282793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Genome edited intestine liver on a chip system for integrated intestinal hepatic drug absorption and metabolism evaluation"],"prefix":"10.1038","volume":"15","author":[{"given":"Ryosuke","family":"Negoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiju","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"22425_CR1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1517\/17425255.4.4.395","volume":"4","author":"H Sun","year":"2008","unstructured":"Sun, H., Chow, E. C., Liu, S., Du, Y. & Pang, K. S. The Caco-2 cell monolayer: usefulness and limitations. Expert Opin. Drug Metab. Toxicol. 4, 395\u2013411 (2008).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"22425_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S1359-6446(04)03354-9","volume":"10","author":"PV Balimane","year":"2005","unstructured":"Balimane, P. V. & Chong, S. Cell culture-based models for intestinal permeability: a critique. Drug Discov. Today 10, 335\u2013343 (2005).","journal-title":"Drug Discov. Today"},{"key":"22425_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bbrc.2023.04.077","volume":"664","author":"K Watanabe","year":"2023","unstructured":"Watanabe, K., Negoro, R. & Fujita, T. 5-ALA treatment increases intracellular heme levels and enhances CYP3A4 activity in genome-edited Caco-2 cells. Biochem. Biophys. Res. Commun. 664, 94\u201399 (2023).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"22425_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00204-021-03175-0","volume":"96","author":"R Negoro","year":"2022","unstructured":"Negoro, R., Yamada, N., Watanabe, K., Kono, Y. & Fujita, T. Generation of Caco-2 cells stably expressing CYP3A4\u00b7POR\u00b7UGT1A1 and CYP3A4\u00b7POR\u00b7UGT1A1*6 using a PITCh system. Arch. Toxicol. 96, 499\u2013510 (2022).","journal-title":"Arch. Toxicol."},{"key":"22425_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0009-2797(99)00088-5","volume":"121","author":"AP Li","year":"1999","unstructured":"Li, A. P. et al. Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. Chem. Biol. Interact. 121, 17\u201335 (1999).","journal-title":"Chem. Biol. Interact."},{"key":"22425_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0041-008X(03)00128-5","volume":"189","author":"EFA Brandon","year":"2003","unstructured":"Brandon, E. F. A., Raap, C. D., Meijerman, I., Beijnen, J. H. & Schellens, J. H. M. An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. Toxicol. Appl. Pharmacol. 189, 233\u2013246 (2003).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"22425_CR7","doi-asserted-by":"publisher","first-page":"13135","DOI":"10.3390\/ijms222313135","volume":"22","author":"VA Arzumanian","year":"2021","unstructured":"Arzumanian, V. A., Kiseleva, O. I. & Poverennaya, E. V. The curious case of the HepG2 cell line: 40 years of expertise. Int. J. Mol. Sci. 22, 13135 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"22425_CR8","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1124\/dmd.109.031831","volume":"38","author":"SN Hart","year":"2010","unstructured":"Hart, S. N. et al. A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues. Drug Metab. Dispos. 38, 988\u2013994 (2010).","journal-title":"Drug Metab. Dispos."},{"key":"22425_CR9","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ejps.2013.08.018","volume":"57","author":"H Musther","year":"2014","unstructured":"Musther, H., Olivares-Morales, A., Hatley, O. J. D., Liu, B. & Rostami Hodjegan, A. Animal versus human oral drug bioavailability: Do they correlate?. Eur. J. Pharm. Sci. 57, 280\u2013291 (2014).","journal-title":"Eur. J. Pharm. Sci."},{"key":"22425_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1124\/dmd.109.028829","volume":"38","author":"T Akabane","year":"2010","unstructured":"Akabane, T. et al. A comparison of pharmacokinetics between humans and monkeys. Drug Metab. Disposit. 38, 308\u2013216 (2010).","journal-title":"Drug Metab. Disposit."},{"key":"22425_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2017.11.001","author":"Y Naritomi","year":"2018","unstructured":"Naritomi, Y., Sanoh, S. & Ohta, S. Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery. Drug Metab. Pharmacokinet. https:\/\/doi.org\/10.1016\/j.dmpk.2017.11.001 (2018).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"22425_CR12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.drudis.2015.09.002","volume":"21","author":"N Scheer","year":"2016","unstructured":"Scheer, N. & Wilson, I. D. A comparison between genetically humanized and chimeric liver humanized mouse models for studies in drug metabolism and toxicity. Drug Discov. Today 21, 250\u2013263 (2016).","journal-title":"Drug Discov. Today"},{"key":"22425_CR13","doi-asserted-by":"publisher","first-page":"100497","DOI":"10.1016\/j.dmpk.2023.100497","volume":"50","author":"N Yamada","year":"2023","unstructured":"Yamada, N., Negoro, R., Watanabe, K. & Fujita, T. Generation of Caco-2 cells with predictable metabolism by CYP3A4, UGT1A1 and CES using the PITCh system. Drug Metab. Pharmacokinet. 50, 100497 (2023).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"22425_CR14","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3390\/cells11101677","volume":"11","author":"R Negoro","year":"2022","unstructured":"Negoro, R., Tasaka, M., Deguchi, S., Takayama, K. & Fujita, T. Generation of HepG2 cells with high expression of multiple drug-metabolizing enzymes for drug discovery research using a PITCh system. Cells 11, 1677 (2022).","journal-title":"Cells"},{"key":"22425_CR15","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1248\/bpb.b24-00202","volume":"47","author":"R Negoro","year":"2024","unstructured":"Negoro, R., Ouchi, A., Deguchi, S., Takayama, K. & Fujita, T. Refining hepatocyte models to capture the impact of CYP2D6*10 utilizing a PITCh system. Biol. Pharm. Bull. 47, 1422\u20131428 (2024).","journal-title":"Biol. Pharm. Bull."},{"key":"22425_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.tcb.2011.09.005","volume":"21","author":"D Huh","year":"2011","unstructured":"Huh, D., Hamilton, G. A. & Ingber, D. E. From 3D cell culture to organs-on-chips. Trends Cell Biol. 21, 745\u2013754 (2011).","journal-title":"Trends Cell Biol."},{"key":"22425_CR17","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/s41573-021-00323-0","volume":"20","author":"P Vulto","year":"2021","unstructured":"Vulto, P. & Joore, J. Adoption of organ-on-chip platforms by the pharmaceutical industry. Nat. Rev. Drug Discov. 20, 961\u2013962. https:\/\/doi.org\/10.1038\/s41573-021-00323-0 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"22425_CR18","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1039\/C9LC00884E","volume":"20","author":"H Arakawa","year":"2020","unstructured":"Arakawa, H. et al. Kinetic analysis of sequential metabolism of triazolam and its extrapolation to humans using an entero-hepatic two-organ microphysiological system. Lab Chip 20, 537\u2013547 (2020).","journal-title":"Lab Chip"},{"key":"22425_CR19","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1038\/s41598-021-84861-y","volume":"11","author":"M Shinohara","year":"2021","unstructured":"Shinohara, M. et al. Coculture with hiPS-derived intestinal cells enhanced human hepatocyte functions in a pneumatic-pressure-driven two-organ microphysiological system. Sci. Rep. 11, 5437 (2021).","journal-title":"Sci. Rep."},{"key":"22425_CR20","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1039\/D2LC00276K","volume":"22","author":"N Milani","year":"2022","unstructured":"Milani, N. et al. Application of a gut-liver-on-a-chip device and mechanistic modelling to the quantitative in vitro pharmacokinetic study of mycophenolate mofetil. Lab Chip 22, 2853\u20132868 (2022).","journal-title":"Lab Chip"},{"key":"22425_CR21","doi-asserted-by":"crossref","unstructured":"Yang, J. et al. Gut-liver-axis microphysiological system for studying cellular fluidic shear stress and inter-tissue interaction. Biomicrofluidics 16, 044113 (2022).","DOI":"10.1063\/5.0088232"},{"key":"22425_CR22","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41551-019-0498-9","volume":"4","author":"A Herland","year":"2020","unstructured":"Herland, A. et al. Quantitative prediction of human pharmacokinetic responses to drugs via fluidically coupled vascularized organ chips. Nat. Biomed. Eng. 4, 421\u2013436 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"22425_CR23","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.1021\/acsbiomaterials.1c00642","volume":"7","author":"S Deguchi","year":"2021","unstructured":"Deguchi, S. et al. Usability of polydimethylsiloxane-based microfluidic devices in pharmaceutical research using human hepatocytes. ACS Biomater. Sci. Eng. 7, 3648\u20133657 (2021).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"22425_CR24","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1021\/jm901371v","volume":"53","author":"MVS Varma","year":"2010","unstructured":"Varma, M. V. S. et al. Physicochemical space for optimum oral bioavailability: Contribution of human intestinal absorption and first-pass elimination. J. Med. Chem. 53, 1098\u20131108 (2010).","journal-title":"J. Med. Chem."},{"key":"22425_CR25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/pharmaceutics16030296","volume":"16","author":"P Carius","year":"2024","unstructured":"Carius, P. et al. Addressing the ADME Challenges of compound loss in a PDMS-based gut-on-chip microphysiological system. Pharmaceutics 16, 296 (2024).","journal-title":"Pharmaceutics"},{"key":"22425_CR26","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1039\/D1LC00348H","volume":"21","author":"J Grant","year":"2021","unstructured":"Grant, J. et al. Simulating drug concentrations in PDMS microfluidic organ chips. Lab Chip 21, 2509\u20133519 (2021).","journal-title":"Lab Chip"},{"key":"22425_CR27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.isci.2019.04.037","volume":"15","author":"W Shin","year":"2019","unstructured":"Shin, W., Hinojosa, C. D., Ingber, D. E. & Kim, H. J. Human intestinal morphogenesis controlled by transepithelial morphogen gradient and flow-dependent physical cues in a microengineered gut-on-a-chip. iScience 15, 391\u2013406 (2019).","journal-title":"iScience"},{"key":"22425_CR28","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.stem.2024.06.012","volume":"31","author":"S Deguchi","year":"2024","unstructured":"Deguchi, S. et al. Construction of multilayered small intestine-like tissue by reproducing interstitial flow. Cell Stem Cell 31, 1315-1326.e8 (2024).","journal-title":"Cell Stem Cell"},{"key":"22425_CR29","doi-asserted-by":"publisher","DOI":"10.1039\/c8lc00869h","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Wang, H., Deng, P., Chen, W. & Guo, Y. In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system. Lab Chip https:\/\/doi.org\/10.1039\/c8lc00869h (2018).","journal-title":"Lab Chip"},{"key":"22425_CR30","first-page":"224","volume":"42","author":"SM Rahman","year":"2025","unstructured":"Rahman, S. M. et al. Opportunities and challenges for human microphysiological systems in drug development. ALTEX-Alternat. Animal Experiment. 42, 224\u2013256 (2025).","journal-title":"ALTEX-Alternat. Animal Experiment."},{"key":"22425_CR31","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1038\/s41598-025-85653-4","volume":"15","author":"I Petit","year":"2025","unstructured":"Petit, I. et al. Proximal tubule-on-chip as a model for predicting cation transport and drug transporter dynamics. Sci. Rep. 15, 2580 (2025).","journal-title":"Sci. Rep."},{"key":"22425_CR32","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jcmgh.2017.12.010","volume":"5","author":"H Intestine","year":"2018","unstructured":"Intestine, H. et al. Microfluidic organ-on-a-chip models of human intestine. Cell Mol. Gastroenterol. Hepatol. 5, 659\u2013668 (2018).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"22425_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/cpt.2907","volume":"114","author":"D Ahire","year":"2023","unstructured":"Ahire, D., Heyward, S. & Prasad, B. Intestinal metabolism of diclofenac by polymorphic UGT2B17 correlates with its highly variable pharmacokinetics and safety across populations. Clin. Pharmacol. Ther. 114, 161\u2013172 (2023).","journal-title":"Clin. Pharmacol. Ther."},{"key":"22425_CR34","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0006-2952(99)00167-7","volume":"58","author":"R Bort","year":"1999","unstructured":"Bort, R. et al. Hepatic metabolism of diclofenac: Role of human CYP in the minor oxidative pathways. Biochem. Pharmacol. 58, 787\u2013796 (1999).","journal-title":"Biochem. Pharmacol."},{"key":"22425_CR35","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.toxlet.2017.11.038","volume":"284","author":"KE Lazarska","year":"2018","unstructured":"Lazarska, K. E., Dekker, S. J., Vermeulen, N. P. E. & Commandeur, J. N. M. Effect of UGT2B7*2 and CYP2C8*4 polymorphisms on diclofenac metabolism. Toxicol. Lett. 284, 70\u201378 (2018).","journal-title":"Toxicol. Lett."},{"key":"22425_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0009-9236(95)90188-4","volume":"58","author":"SK Hukkinen","year":"1995","unstructured":"Hukkinen, S. K., Varhe, A., Olkkola, K. T. & Neuvonen, P. J. Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clin. Pharmacol. Ther. 58, 127\u2013131 (1995).","journal-title":"Clin. Pharmacol. Ther."},{"key":"22425_CR37","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/clpt.1994.184","volume":"56","author":"A Varhe","year":"1994","unstructured":"Varhe, A., Olkkola, K. T. & Neuvonen, P. J. Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole. Clin. Pharmacol. Ther. 56, 601\u2013607 (1994).","journal-title":"Clin. Pharmacol. Ther."},{"key":"22425_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.clpt.2004.02.007","volume":"75","author":"SM Kakar","year":"2004","unstructured":"Kakar, S. M., Paine, M. F., Stewart, P. W. & Watkins, P. B. 6\u20327\u2032-dihydroxybergamottin contributes to the grapefruit juice effect. Clin. Pharmacol. Ther. 75, 569\u2013579 (2004).","journal-title":"Clin. Pharmacol. Ther."},{"key":"22425_CR39","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0090-9556(24)15346-9","volume":"28","author":"LQ Guo","year":"2000","unstructured":"Guo, L. Q., Fukuda, K., Ohta, T. & Yamazoe, Y. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab. Dispos. 28, 766\u2013771 (2000).","journal-title":"Drug Metab. Dispos."},{"key":"22425_CR40","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/bit.20744","volume":"93","author":"CR Otey","year":"2006","unstructured":"Otey, C. R., Bandara, G., Lalonde, J., Takahashi, K. & Arnold, F. H. Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450. Biotechnol. Bioeng. 93, 494\u2013499 (2006).","journal-title":"Biotechnol. Bioeng."},{"key":"22425_CR41","first-page":"1377","volume":"29","author":"AL Upthagrove","year":"2001","unstructured":"Upthagrove, A. L. & Nelson, W. L. Importance of amine pKa and distribution coefficient in the metabolism of fluorinated propranolol derivatives. Preparation, identification of metabolite regioisomers, and metabolism by CYP2D6. Drug Metab. Dispos. 29, 1377\u20131388 (2001).","journal-title":"Drug Metab. Dispos."},{"key":"22425_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0090-9556(25)08146-2","volume":"13","author":"T Walle","year":"1985","unstructured":"Walle, T., Walle, U. K. & Olanoff, L. S. Quantitative account of propranolol metabolism in urine of normal man. Drug Metab. Dispos. 13, 204\u2013209 (1985).","journal-title":"Drug Metab. Dispos."},{"key":"22425_CR43","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1038\/s41598-018-21201-7","volume":"8","author":"M Kasendra","year":"2018","unstructured":"Kasendra, M. et al. Development of a primary human Small Intestine-on-a-Chip using biopsy-derived organoids. Sci. Rep. 8, 2871 (2018).","journal-title":"Sci. Rep."},{"key":"22425_CR44","doi-asserted-by":"publisher","first-page":"E10539","DOI":"10.1073\/pnas.1810819115","volume":"115","author":"W Shin","year":"2018","unstructured":"Shin, W. & Kim, H. J. Intestinal barrier dysfunction orchestrates the onset of inflammatory host\u2013microbiome cross-talk in a human gut inflammation-on-a-chip. Proc. Natl. Acad. Sci. 115, E10539\u2013E10547 (2018).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"22425_CR45","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1039\/D4BM01273A","volume":"13","author":"W Hu","year":"2025","unstructured":"Hu, W. et al. Microfluidic organ-on-a-chip models for the gut\u2013liver axis: from structural mimicry to functional insights. Biomater. Sci. 13, 1624\u20131656 (2025).","journal-title":"Biomater. Sci."},{"key":"22425_CR46","first-page":"10510","volume":"13","author":"Y Sakai","year":"2023","unstructured":"Sakai, Y. et al. Development of a perfusing small intestine-liver microphysiological system device. Appl. Sci. (Switzerland) 13, 10510 (2023).","journal-title":"Appl. Sci. (Switzerland)"},{"key":"22425_CR47","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.tiv.2014.02.005","volume":"28","author":"T Bricks","year":"2014","unstructured":"Bricks, T. et al. Development of a new microfluidic platform integrating co-cultures of intestinal and liver cell lines. Toxicol. Vitro 28, 885\u2013895 (2014).","journal-title":"Toxicol. Vitro"},{"key":"22425_CR48","first-page":"4635","volume":"10","author":"M Wang","year":"2024","unstructured":"Wang, M. et al. Perfluoropolyether-based gut-liver-on-a-chip for the evaluation of first-pass metabolism and oral bioavailability of drugs. Cite This: ACS Biomater. Sci. Eng. 10, 4635\u20134644 (2024).","journal-title":"Cite This: ACS Biomater. Sci. Eng."},{"key":"22425_CR49","doi-asserted-by":"publisher","first-page":"24859","DOI":"10.1021\/acsomega.1c03719","volume":"6","author":"E Sano","year":"2021","unstructured":"Sano, E. et al. Generation of tetrafluoroethylene-propylene elastomer-based microfluidic devices for drug toxicity and metabolism studies. ACS Omega 6, 24859\u201324865 (2021).","journal-title":"ACS Omega"},{"key":"22425_CR50","doi-asserted-by":"publisher","first-page":"38541","DOI":"10.1021\/acsami.2c10669","volume":"14","author":"DB Mair","year":"2022","unstructured":"Mair, D. B. et al. PDMS-PEG block copolymer and pretreatment for arresting drug absorption in microphysiological devices. ACS Appl. Mater. Interfaces 14, 38541\u201324548 (2022).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"22425_CR51","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/mi14040761","volume":"14","author":"R Ueno","year":"2023","unstructured":"Ueno, R. et al. Relationship between adsorption and toxicity of nephrotoxic drugs in microphysiological systems (MPS). Micromachines (Basel) 14, 761 (2023).","journal-title":"Micromachines (Basel)"},{"key":"22425_CR52","doi-asserted-by":"publisher","first-page":"122253","DOI":"10.1016\/j.ijpharm.2022.122253","volume":"627","author":"M Wang","year":"2022","unstructured":"Wang, M. et al. Application of perfluoropolyether elastomers in microfluidic drug metabolism assays. Int. J. Pharm. 627, 122253 (2022).","journal-title":"Int. J. Pharm."},{"key":"22425_CR53","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1039\/D0LC00770F","volume":"21","author":"A Nicolas","year":"2021","unstructured":"Nicolas, A. et al. High throughput transepithelial electrical resistance (TEER) measurements on perfused membrane-free epithelia. Lab Chip 21, 1676\u20131685 (2021).","journal-title":"Lab Chip"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22425-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22425-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22425-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T20:03:16Z","timestamp":1762286596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-22425-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22425"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-22425-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"While writing this manuscript, the authors used DeepL, Grammarly, ChatGPT, and Claude to improve the grammatical accuracy and readability of the English. After using these tools, they carefully reviewed and edited the content as needed and are fully responsible for the publication content.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI and AI-assisted technologies in the writing process"}}],"article-number":"38609"}}